These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 22093213

  • 1. Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease.
    Zacharski LR, Shamayeva G, Chow BK.
    Am Heart J; 2011 Nov; 162(5):949-957.e1. PubMed ID: 22093213
    [Abstract] [Full Text] [Related]

  • 2. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
    Depalma RG, Hayes VW, Chow BK, Shamayeva G, May PE, Zacharski LR.
    J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
    [Abstract] [Full Text] [Related]

  • 3. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.
    Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.
    J Natl Cancer Inst; 2008 Jul 16; 100(14):996-1002. PubMed ID: 18612130
    [Abstract] [Full Text] [Related]

  • 4. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial.
    Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.
    JAMA; 2007 Feb 14; 297(6):603-10. PubMed ID: 17299195
    [Abstract] [Full Text] [Related]

  • 5. Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST).
    Zacharski LR, Chow BK, Howes PS, Lavori PW, Shamayeva G.
    Am Heart J; 2004 Sep 14; 148(3):386-92. PubMed ID: 15389223
    [Abstract] [Full Text] [Related]

  • 6. Reduction of iron stores and clinical outcomes in peripheral arterial disease: outcome comparisons in smokers and non-smokers.
    DePalma RG, Zacharski LR, Chow BK, Shamayeva G, Hayes VW.
    Vascular; 2013 Aug 14; 21(4):233-41. PubMed ID: 23518844
    [Abstract] [Full Text] [Related]

  • 7. Iron reduction benefits: positive results from a "negative" prospective randomized controlled trial.
    Depalma RG, Zacharski LR.
    Vasc Endovascular Surg; 2012 Oct 14; 46(7):596-7. PubMed ID: 22903331
    [No Abstract] [Full Text] [Related]

  • 8. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.
    Biol Blood Marrow Transplant; 2010 Jan 14; 16(1):115-22. PubMed ID: 19766730
    [Abstract] [Full Text] [Related]

  • 9. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
    Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S.
    Am J Gastroenterol; 2007 Jun 14; 102(6):1251-8. PubMed ID: 17391316
    [Abstract] [Full Text] [Related]

  • 10. Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic determinants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119: 123-130.
    Kreatsoulas C, Anand SS.
    Vasc Med; 2009 Nov 14; 14(4):397-9. PubMed ID: 19808727
    [Abstract] [Full Text] [Related]

  • 11. Statin use and survival outcomes in elderly patients with heart failure.
    Ray JG, Gong Y, Sykora K, Tu JV.
    Arch Intern Med; 2005 Jan 10; 165(1):62-7. PubMed ID: 15642876
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EM, TRITON-TIMI 38 Investigators.
    Circulation; 2008 Oct 14; 118(16):1626-36. PubMed ID: 18757948
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY, Fiaccadori V, Gandhi S, Hayden J, Kenyon M, Ireland R, Marsh J, Ho AY, Mufti GJ, Pagliuca A.
    Leuk Res; 2010 Jun 14; 34(6):723-7. PubMed ID: 19944463
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR, Giugliano RP, Mohanavelu S, Murphy SA, McCabe CH, Cannon CP, Braunwald E.
    J Am Coll Cardiol; 2008 Sep 09; 52(11):914-20. PubMed ID: 18772061
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ.
    J Am Coll Cardiol; 2010 Oct 19; 56(17):1366-75. PubMed ID: 20946993
    [Abstract] [Full Text] [Related]

  • 19. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
    Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, O'Neill WW, Wijns W, Serruys PW.
    Am Heart J; 2005 Mar 19; 149(3):512-9. PubMed ID: 15864241
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
    Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B, Wallentin L, FIR Collaboration.
    J Am Coll Cardiol; 2010 Jun 01; 55(22):2435-45. PubMed ID: 20359842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.